Professor Bruno Lina
Head of the Diagnostic Virology Laboratories in Lyon
Born in Lyon, France in 1961, Bruno Lina enrolled at his local
medical school in 1979 and qualified as a doctor of medicine in
1986. He went on to study further, obtaining a PhD in microbiology
before rising through the ranks to become a full Professor of Medicine
(Microbiology) at the University of Lyon in 2000. He has held a
number of key positions in his career, including Head of the National
Reference Centre for Influenza for the South of France, Head of
the National Reference Centre for Enteroviruses, Head of the WHO
Collaborative Centre for Virus Reference and Research and Head of
the Diagnostic Virology Laboratories in Lyon. He is also President
of the Biology Commission at Hospices Civils de Lyon, Vice-president
of the European Society for Clinical Virology, and a Member of the
Scientific Advisory Board of QCMD (Quality Control for Molecular
Professor Lina is currently involved in two EU funded projects.
He was one of the founding members of a network of networks called
IASS (European Influenza Surveillance Scheme), where his work includes
his responsibilities as the Head of the National Reference Centre
for Influenza for the South of France.
He is also involved with the European Surveillance Network for
Vigilance Against Viral Resistance (VIRGIL). In fact he was involved
in VIRGIL right from its outset as a member of the Steering Committee.
This network of excellence aims to integrate and coordinate the
activities of doctors and scientists from institutions across Europe
who are investigating viral resistance. Professor Lina heads the
surveillance platform for influenza.
The Professor's current responsibilities within VIRGIL include
implementing three programs to monitor the rate of emergence of
resistant viruses during the use of antiviral agents within very
specific cores of patients.
The first program is looking at people who are chronically infected
with hepatitis B or C and who may acquire influenza within the next
epidemic. These patients are being administered Oseltamivir and
the Professor's team is monitoring the possible emergence of a resistant
virus in these patients.
The second program involves a similar method of work but with HIV-positive
patients. The third group covers elderly institutionalized patients
who are being given antiviral agents. The possible emergence of
resistance will be studied in both of these groups.
Professor Lina is also involved in providing support ‚ if
needed ‚ to foreign virologists and epidemiologists to help
them cope with the recent outbreak of avian influenza in their country.
This is likely to take the form of technical and personnel support.
The Professor considers his greatest achievement to date to be
his cooperation with the French Ministry of Health to organize France's
response to a possible influenza pandemic. As can be imagined, this
was a huge job which involved liaising with a number of diverse
groups. Many of the Professor's recommendations were taken on-board
and he is delighted that France is now one of the more well-prepared
countries in the world. The French Minister of Health is currently
sharing this expertise with colleagues from some other EU countries.
VIRGIL: European vigilance network
for the management of drug-resistant viruses.
Prof. Bruno Lina
Université Claude Bernard, Laboratoire de Virologie
69373 Lyon Cedex France